{
  "ir_kind": "core",
  "metadata": {
    "source": {
      "id": "s41596-025-01197-x.pdf",
      "type": "paper"
    },
    "title": "Protocol"
  },
  "protocol": {
    "detail_level": 0,
    "edges": [
      {
        "from": "s1",
        "to": "s2"
      },
      {
        "from": "s2",
        "to": "s3"
      },
      {
        "from": "s3",
        "to": "s4"
      },
      {
        "from": "s4",
        "to": "s5"
      },
      {
        "from": "s5",
        "to": "s6"
      },
      {
        "from": "s6",
        "to": "s7"
      },
      {
        "from": "s7",
        "to": "s8"
      },
      {
        "from": "s8",
        "to": "s9"
      },
      {
        "from": "s9",
        "to": "s10"
      },
      {
        "from": "s10",
        "to": "s11"
      }
    ],
    "start_step_id": "s1",
    "step_order": null,
    "steps": [
      {
        "annotations": {
          "note": "It might be difficult to identify a SNR using a stereoscope and to perform a clean SNR isolation. Initially isolated SNR-containing tissue may contain no SNRs, a small SNR or multiple rosettes. Such isolations will probably fail to grow or transform into multi-lumen-containing organoids."
        },
        "id": "s1",
        "inputs": [],
        "op": "annotate",
        "outputs": [],
        "params": {}
      },
      {
        "annotations": {
          "note": "The size and shape of SNRs varies substantially even within a single well. We most often isolate SNRs that are at least 200 μm in diameter with a clearly distinguishable single lumen without taking the shapes of the lumen and rosette into consideration. Isolated SNRs have a mean ± s.e.m. diameter of 297 ± 3 μm (95% confidence interval: 290.6–303.3 μm)."
        },
        "id": "s2",
        "inputs": [],
        "op": "annotate",
        "outputs": [],
        "params": {}
      },
      {
        "annotations": {
          "note": "New methods using spatially confined micropatterned substrates have been developed for generating uniform SNRs with defined size and shape. These innovations may enhance efficiency of generating uniform SNR-derived organoids and explore effects of SNR size and shape on cell properties and organization."
        },
        "id": "s3",
        "inputs": [],
        "op": "annotate",
        "outputs": [],
        "params": {}
      },
      {
        "annotations": {
          "note": "Non-uniform lamination of organoid tissue is a potential limitation. Regions with predictably organized neural cells coexist with regions of unclear or no organization. Disorganized areas are readily identifiable by visual inspection and are excluded from imaging and electrophysiology experiments. Impact on overall organoid development remains unclear."
        },
        "id": "s4",
        "inputs": [],
        "op": "annotate",
        "outputs": [],
        "params": {}
      },
      {
        "annotations": {
          "note": "Other limitations common to most organoid protocols include absence of vasculature (limiting oxygen/nutrient delivery), lack of microglia (affecting cell/synapse regulation), and absence of neuronal inputs from sensory organs or other brain regions (preventing recapitulation of complex brain network information flow). Xenotransplantation of human organoids into rodent brain has been used to overcome some limitations."
        },
        "id": "s5",
        "inputs": [],
        "op": "annotate",
        "outputs": [],
        "params": {}
      },
      {
        "annotations": {
          "note": "The organoid generation protocol consists of five stages: (1) PS cell maintenance and propagation, (2) neural induction, (3) NR formation and isolation, (4) organoid formation from isolated SNRs, and (5) organoid maturation."
        },
        "id": "s6",
        "inputs": [],
        "op": "annotate",
        "outputs": [],
        "params": {}
      },
      {
        "annotations": {
          "note": "It is essential to use validated and characterized human stem cell lines. Insufficiently characterized lines may lead to irreproducible results. Follow standards from the International Society for Stem Cell Research."
        },
        "id": "s7",
        "inputs": [],
        "op": "annotate",
        "outputs": [],
        "params": {}
      },
      {
        "annotations": {
          "note": "Well-characterized human stem cell lines are available from WiCell, Allen Institute for Cell Sciences, National Institute of Mental Health, Simons Foundation Autism Research Initiative, and California Institute for Regenerative Medicine."
        },
        "id": "s8",
        "inputs": [],
        "op": "annotate",
        "outputs": [],
        "params": {}
      },
      {
        "annotations": {
          "note": "For disease modeling studies, include isogenic engineered lines as controls. The most controlled approach is conditional CRE- or FLP-mediated induction/rescue of genetic abnormality during differentiation."
        },
        "id": "s9",
        "inputs": [],
        "op": "annotate",
        "outputs": [],
        "params": {}
      },
      {
        "annotations": {
          "note": "Conditional CRE- or FLP-mediated induction/rescue has been successfully used for studying autism spectrum disorder-, schizophrenia-, and Alzheimer’s disease-associated genetic abnormalities, but not yet for large genetic abnormalities."
        },
        "id": "s10",
        "inputs": [],
        "op": "annotate",
        "outputs": [],
        "params": {}
      },
      {
        "annotations": {
          "note": "In a previous study, a pair of guide RNAs was used to excise a complete copy of SHANK3 (~69.5 kB) in human PS cells."
        },
        "id": "s11",
        "inputs": [],
        "op": "annotate",
        "outputs": [],
        "params": {}
      }
    ]
  },
  "resources": {
    "containers": [],
    "data": [],
    "equipment": [],
    "materials": [],
    "samples": []
  },
  "schema_version": "0.4"
}
